Seeking Alpha

  Arrowhead Research Corporation (ARWR) - NASDAQ

  • World Market Media | Send Message 8 Jun 2010

    Arrowhead Research Corporation (NASDAQ: ARWR) $107M (MarketCap) Receives Grant from the State of Texas http://bit.ly/cpeyw9
    Reply
      ARWR vs. ETF Alternatives
      Company Description
      Arrowhead Research Corp is engaged in developing novel drugs to treat intractable diseases by silencing the genes. The Company's drug candidate ARC-520 is designed to treat chronic hepatitis B infection.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States